Invention Grant
- Patent Title: Soluble guanylate cyclase activators
- Patent Title (中): 可溶性鸟苷酸环化酶活化剂
-
Application No.: US12674795Application Date: 2008-09-02
-
Publication No.: US08455638B2Publication Date: 2013-06-04
- Inventor: Amy R. Bittner , Ronald M. Kim , John W. Mirc , Emma R. Parmee , Christopher Joseph Sinz , Qiang Tan
- Applicant: Amy R. Bittner , Ronald M. Kim , John W. Mirc , Emma R. Parmee , Christopher Joseph Sinz , Qiang Tan
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Carol S. Quagliato; Catherine D. Fitch
- International Application: PCT/US2008/010321 WO 20080902
- International Announcement: WO2009/032249 WO 20090312
- Main IPC: C07D345/00
- IPC: C07D345/00 ; C07D517/00 ; C07D413/00 ; C07D401/00

Abstract:
A compound having the structure useful for treatment or prevention of cardiovascular diseases, endothelial dysfunction, diastolic dysfunction, atherosclerosis, hypertension, angina pectoris, thromboses, restenoses, myocardial infarction, strokes, cardiac insufficiency, pulmonary hypertonia, erectile dysfunction, asthma bronchiale, chronic kidney insufficiency, diabetes, or cirrhosis of the liver in a human or animal patient.
Public/Granted literature
- US20110118282A1 Soluble Guanylate Cyclase Activators Public/Granted day:2011-05-19
Information query